Beijing Sl Pharmaceutical: Announcement of implementation of annual equity distribution of Beijing SL Pharmaceutical Co., Ltd. in 2023.
Beijing Sl Pharmaceutical: Peking SL Pharmaceutical Co., Ltd. Announcement on Pre-disclosure of Shareholding Reduction by Senior Management Personnel
Shuanglu Pharmaceutical: Announcement of Beijing Shuanglu Pharmaceutical Co., Ltd. on the expiration of the senior management holdings reduction plan and the failure to implement holdings reduction
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.\'s 2022 Annual Equity Distribution Implementation Notice
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.\'s pre-disclosure announcement on senior managers\' plans to continue to reduce their holdings after the expiration of the shareholding reduction plan
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.\'s announcement on the completion of the holdings reduction plan for the second largest shareholder of the company
Shuanglu Pharmaceutical: Announcement by Beijing Shuanglu Pharmaceutical Co., Ltd. on the illegal reduction of shares and an apology by the controlling shareholders and executives of the company's holdings due to misoperation by the controlling shareholder
Shuanglu Pharmaceutical: An indicative announcement by Beijing Shuanglu Pharmaceutical Co., Ltd. on the change in shareholding ratio of more than 5% due to the redeemable debt exchange and reduction of holdings by the second largest shareholder of the comp
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement on the progress of more than half of the holdings reduction plans of the company's second largest shareholder
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd. Simplified Equity Change Report
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.\'s announcement on the progress of the company\'s second-largest shareholder\'s holdings reduction plan past half of the time planned
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement on the completion of the delisting of non-public exchangeable corporate bonds issued by the second largest shareholder and the cancellation of the pledge of some shares
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement that participating companies publicly issue shares to unspecified qualified investors and are listed on the Beijing Stock Exchange with the approval of the China Securities R
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s pre-disclosure announcement on the second largest shareholder's holdings reduction plan
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement on the progress of senior managers' holdings reduction plan halfway through the planned period
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement on the cancellation of the pledge of some of the shares of the second largest shareholder
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement on the progress of the exchange of non-public exchangeable corporate bonds issued by the company's second largest shareholder and the equity change ratio due to the exchange
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s 2020 Annual Equity Distribution Implementation Notice
Shuanglu Pharmaceutical: Announcement by Beijing Shuanglu Pharmaceutical Co., Ltd. on the progress and changes in equity of the company's second-largest shareholder issuing exchangeable corporate bonds to exchange shares
Shuanglu Pharmaceutical: Announcement on the second largest shareholder's share pledge
No Data
No Data